Lumora's "BART" technology represents a unique, highly differentiated platform for molecular diagnostics. 

Despite the enormous benefits molecular methods bring to clinical diagnostics, existing technologies are associated with high complexity and cost and often require specialist users and facilities.

The BART techhnology makes molecular diagnostics low-cost, robust and, above all, easy.

BART technology brings the benefits of molecular diagnostics to any niche, whether this be a farmer's field, a hospital ward or an airport, as well as providing a highly competitive solution for specialist high throughput clinical laboratories. 

Lumora is actively seeking further partners to co-develop products based on the BART technology in key sectors of the clinical IVD market.